Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 3751 AL 3765

Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs

Iglesias J, Morales L, Barreto GE.

Mol Neurobiol. 2017 May;54(4):2518-2538. doi: 10.1007/s12035-016-9833-2. Epub 2016 Mar 17.

Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review

Andersen AD, Binzer M, Stenager E, Gramsbergen JB.

Acta Neurol Scand. 2017 Jan;135(1):34-56. doi: 10.1111/ane.12590. Epub 2016 Mar 18.

Prospective study on cost-effectiveness of home-based motor assessment in Parkinson's disease

Cubo E, Mariscal N, Solano B, Becerra V, Armesto D, Calvo S, Arribas J, Seco J, Martinez A, Zorrilla L, Heldman D.

J Telemed Telecare. 2017 Feb;23(2):328-338. doi: 10.1177/1357633X16638971. Epub 2016 Jul 8.

Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

De Deurwaerdère P, Di Giovanni G.

Prog Neurobiol. 2017 Apr;151:175-236. doi: 10.1016/j.pneurobio.2016.03.004. Epub 2016 Mar 22.

Acute dystonic reaction in a patient with Parkinson's disease after diphenhydramine withdrawal

Jacob S, Ly H, Villenueva RJ, Gupta HV.

Acta Neurol Belg. 2017 Mar;117(1):345-346. doi: 10.1007/s13760-016-0626-1. Epub 2016 Mar 25.

Parkinsonism and cognitive impairment due to a giant frontal arachnoid cyst and improving after shunting

Mormont E, Dorban S, Gustin T.

Acta Neurol Belg. 2017 Mar;117(1):347-349. doi: 10.1007/s13760-016-0632-3. Epub 2016 Mar 29.

Gamma knife radiosurgery in movement disorders: Indications and limitations

Higuchi Y, Matsuda S, Serizawa T.

Mov Disord. 2017 Jan;32(1):28-35. doi: 10.1002/mds.26625. Epub 2016 Mar 31.

RBD and Neurodegenerative Diseases

Jiang H, Huang J, Shen Y, Guo S, Wang L, Han C, Liu L, Ma K, Xia Y, Li J, Xu X, Xiong N, Wang T.

Mol Neurobiol. 2017 May;54(4):2997-3006. doi: 10.1007/s12035-016-9831-4. Epub 2016 Mar 31.

Comparison between two functional mobility scales for Parkinson's disease directly applied to physical therapy practice: cross-cultural adaptation and measurement properties

Santos MP, da Silva BA, Ovando AC, Ilha J, Swarowsky A.

Eur J Phys Rehabil Med. 2017 Oct;53(5):664-675. doi: 10.23736/S1973-9087.16.04148-4. Epub 2016 Apr 6.

Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research

Litim N, Morissette M, Di Paolo T.

Neuropharmacology. 2017 Mar 15;115:166-179. doi: 10.1016/j.neuropharm.2016.03.036. Epub 2016 Apr 4.

Onset and progression factors in Parkinson's disease: A systematic review

Martino R, Candundo H, Lieshout PV, Shin S, Crispo JAG, Barakat-Haddad C.

Neurotoxicology. 2017 Jul;61:132-141. doi: 10.1016/j.neuro.2016.04.003. Epub 2016 Apr 5.

The emerging role of transcranial magnetic resonance imaging-guided focused ultrasound in functional neurosurgery

Weintraub D, Elias WJ.

Mov Disord. 2017 Jan;32(1):20-27. doi: 10.1002/mds.26599. Epub 2016 Apr 8.

Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease

Lim CK, Fernández-Gomez FJ, Braidy N, Estrada C, Costa C, Costa S, Bessede A, Fernandez-Villalba E, Zinger A, Herrero MT, Guillemin GJ.

Prog Neurobiol. 2017 Aug;155:76-95. doi: 10.1016/j.pneurobio.2015.12.009. Epub 2016 Apr 9.

Effect of low-frequency deep brain stimulation on sensory thresholds in Parkinson's disease

Belasen A, Rizvi K, Gee LE, Yeung P, Prusik J, Ramirez-Zamora A, Hanspal E, Paiva P, Durphy J, Argoff CE, Pilitsis JG.

J Neurosurg. 2017 Feb;126(2):397-403. doi: 10.3171/2016.2.JNS152231. Epub 2016 Apr 22.

Microglial phenotypes in Parkinson's disease and animal models of the disease

Joers V, Tansey MG, Mulas G, Carta AR.

Prog Neurobiol. 2017 Aug;155:57-75. doi: 10.1016/j.pneurobio.2016.04.006. Epub 2016 Apr 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias